Drug Database
Back to search

Poland· PL-100433109

Oxytocin Grindeks

A oxytocin product containing oxytocinum, registered in Poland by AS Grindeks. The same ATC class is registered in 16 of our 19 countries.

ATC H01BB02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOxytocin GrindeksATCH01BB02REGISTER NO.PL-100433109PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxytocinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxytocin is registered in 16 of 19 countries.

Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search oxytocin products by name

Oxytocin · ATC H01BB02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Oxytocinum
Manufacturer
AS Grindeks
Country
Poland (PL)
ATC code
H01BB02
ATC class
Oxytocin
Defined daily dose
15 E, N
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991446499
  • gtin
    05909991446505
  • gtin
    05909991446512

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

303 interactions on record for oxytocin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxytocin against other medicinesHow interaction checks work

Oxytocin · interactions on record

303 records

  • 71 severe
  • 228 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxytocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxytocin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Oxytocin Grindeks, Syntocinon
  • Belgium · Oxytocin Grindeks, Syntocinon
  • Bulgaria · Окситоцин Pихtep
  • Cyprus · Syntocinon
  • Czechia · Ofost, Oxytocin Avmc
  • Germany · Oxytocin Hexal, Oxytocin Panpharma
  • Denmark · Oxytocin Orifarm, Syntocinon
  • Estonia · Oxytocin Grindeks
  • Spain · Oxitocina Grindeks, Syntocinon
  • Finland · Oxytocin Orifarm, Syntocinon
  • France · Oxytocine Ever Pharma, Oxytocine Grindeks
  • United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
  • Greece · Oxytocin Gap
  • Croatia · Syntocinon
  • Hungary · Oxytocin Grindeks, Oxytocin Panpharma
  • Ireland · Ofost, Oxytocin Pinewood Laboratories
  • Iceland · Syntocinon
  • Italy · Ossitocina Grindeks, Syntocinon
  • Lithuania · Ofost, Oxytocin Grindeks
  • Latvia · Ofost, Oxytocin Grindeks
  • Malta · Oxytocin Wockhardt, Syntocinon
  • Netherlands · Syntocinon
  • Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
  • Portugal · Oxitocina Generis, Oxitocina Grindeks
  • Romania · Ofost, Oxitocină Panpharma
  • Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
  • Slovenia · Ofost, Syntocinon
  • Slovakia · Ofost, Oxygrindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7094c78d-04e3-49b1-9e3a-0fd67994d7c8
GET /v1/drugs/7094c78d-04e3-49b1-9e3a-0fd67994d7c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań / do infuzji",
  "source": "urpl",
  "strength": "8,3 mcg/ml",
  "packaging": "05909991446499 ¦ Lz ¦ 138983\n5 amp. 1 ml\n05909991446505 ¦ Lz ¦ 138984\n10 amp. 1 ml\n05909991446512 ¦ Lz ¦ 138985\n100 amp. 1 ml",
  "substance": "Oxytocinum 8.3 mcg/1 ml",
  "common_name": "Oxytocinum",
  "pl_product_id": "100433109",
  "pozwolenie_nr": "26616",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about oxytocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console